Annual report [Section 13 and 15(d), not S-K Item 405]

Stock-Based Compensation (Tables)

v3.25.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Restricted Stock Unit Activity

A summary of our restricted stock unit activity is set forth below:
 

 

Shares

 

 

Weighted Average Grant Date Fair Value

 

Outstanding as of December 31, 2023

 

 

96,808

 

 

$

25.21

 

Granted

 

 

84,089

 

 

 

5.63

 

Released

 

 

(131,226

)

 

 

13.40

 

Forfeited

 

 

(11,251

)

 

 

24.18

 

Outstanding as of December 31, 2024

 

 

38,420

 

 

$

23.01

 

Schedule of Stock Option Activity

A summary of our stock option activity under the 2018 Plan and related information is as follows:
 

 

Number of Shares

 

 

Weighted Average
Exercise Price

 

 

Weighted Average
Remaining
Contractual Term
(years)

 

 

Aggregate Intrinsic
Value

 

Outstanding as of December 31, 2023

 

 

2,500

 

 

$

56.89

 

 

 

4.19

 

 

$

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

Cancelled/Expired

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding as of December 31, 2024

 

 

2,500

 

 

$

56.89

 

 

 

3.19

 

 

$

 

Exercisable as of December 31, 2024

 

 

2,500

 

 

$

56.89

 

 

 

3.19

 

 

$

 

 

A summary of our stock option activity under the 2009 Plan and related information is set forth below:
 

 

Number of Shares

 

 

Weighted Average Exercise Price

 

 

Weighted Average Remaining
Contractual Term (years)

 

 

Aggregate Intrinsic Value

 

Outstanding as of December 31, 2023

 

 

14,625

 

 

$

39.67

 

 

 

2.94

 

 

$

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

Cancelled/Expired

 

 

(13,435

)

 

 

35.07

 

 

 

 

 

 

 

Outstanding as of December 31, 2024

 

 

1,190

 

 

$

91.64

 

 

 

2.50

 

 

$

 

Exercisable as of December 31, 2024

 

 

1,190

 

 

$

91.61

 

 

 

2.50

 

 

$

 

Schedule of Stock-Based Compensation

Compensation cost that has been included in our consolidated statements of operations and comprehensive loss for all stock-based compensation arrangements is set forth below:
 

 

Year ended December 31,

 

Stock-based compensation

 

2024

 

 

2023

 

Cost of revenues

 

$

179

 

 

$

447

 

Sales and marketing

 

 

65

 

 

 

135

 

General and administrative

 

 

1,341

 

 

 

3,294

 

Research and development

 

 

71

 

 

 

195

 

Total stock-based compensation

 

$

1,656

 

 

$

4,071